First bivalent fully antagonist anti-c-Met antibody targeting the c-Met receptor: II) in vivo activity

被引：0
|
作者：
Goetsch, Liliane [1 ]
Lepecquet, Anne-Marie [1 ]
Geronimi, Fabien [1 ]
Gonzalez, Alexandra [1 ]
Robert, Alain [1 ]
Chenu, Stephane [1 ]
Corbiere, Jean-Claude [1 ]
Bailly, Christian [1 ]
Corvaia, Nathalle [1 ]
机构：
[1] Inst Rech Pierre Fabre, St Julien En Genevois, France
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2792
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Preparation of a Novel One-Armed Anti-c-Met Antibody with Antitumor Activity Against Hepatocellular Carcinoma
    Yin, Yanxin
    Guo, Jia
    Teng, Fei
    Yu, Lihua
    Jiang, Yun
    Xie, Kun
    Jiang, Ming
    Fang, Jianmin
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 : 4173 - 4184
  • [22] Single or combined in vivo therapies of cancer with h224G11, a humanized antibody targeting the c-Met receptor
    Goetsch, Liliane
    Gonzalez, Alexandra
    Geronimi, Fabien
    Fabre-Lafay, Stephanie
    Broussas, Matthieu
    Lepecquet, Anne-Marie
    Wurch, Thierry
    Corvaia, Nathalie
    Bailly, Christian
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [23] Targeting c-Met in triple negative breast cancer: preclinical studies using the c-Met inhibitor, Cpd A
    Breen, Laura
    Gaule, Patricia B.
    Canonici, Alexandra
    Walsh, Naomi
    Collins, Denis M.
    Cremona, Mattia
    Hennessy, Bryan T.
    Duffy, Michael J.
    Crown, John
    O' Donovan, Norma
    Eustace, Alex J.
    INVESTIGATIONAL NEW DRUGS, 2020, 38 (05) : 1365 - 1372
  • [24] Targeting c-Met in triple negative breast cancer: preclinical studies using the c-Met inhibitor, Cpd A
    Laura Breen
    Patricia B. Gaule
    Alexandra Canonici
    Naomi Walsh
    Denis M. Collins
    Mattia Cremona
    Bryan T. Hennessy
    Michael J. Duffy
    John Crown
    Norma O’ Donovan
    Alex J. Eustace
    Investigational New Drugs, 2020, 38 : 1365 - 1372
  • [25] Single chain anti-c-Met antibody conjugated nanoparticles for in vivo tumor-targeted imaging and drug delivery
    Lu, Ruei-Min
    Chang, Yu-Ling
    Chen, Min-Shan
    Wu, Han-Chung
    BIOMATERIALS, 2011, 32 (12) : 3265 - 3274
  • [26] A novel c-Met/EGFR bispecific targeting antibody drug conjugate for NSCLC
    Chen, Gang
    Li, Lingna
    Muyot, Pia
    Gros, Edwige
    Zhang, Yanliang
    Sun, Yingqing
    Zhang, Hong
    Fu, Yanwen
    Lee, Alice
    Cao, Jian
    Kaufmann, Gunnar
    Miao, Zhenwei
    CANCER RESEARCH, 2015, 75
  • [27] Experimental study on the regulation of erlotinib-induced radiosensitization with an anti-c-MET monoclonal antibody
    Zhuang, Hong-Qing
    Zhuang, Hongxia
    Bo, Qifu
    Guo, Yihang
    Wang, Jun
    Zhao, Lu-Jun
    Yuan, Zhi-Yong
    Wang, Ping
    CANCER CELL INTERNATIONAL, 2014, 14
  • [28] Structural basis of the activation of c-MET receptor
    Uchikawa, Emiko
    Chen, Zhiming
    Xiao, Guan-Yu
    Zhang, Xuewu
    Bai, Xiao-chen
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [29] Experimental study on the regulation of erlotinib-induced radiosensitization with an anti-c-MET monoclonal antibody
    Hong-Qing Zhuang
    Hongxia Zhuang
    Qifu Bo
    Yihang Guo
    Jun Wang
    Lu-Jun Zhao
    Zhi-Yong Yuan
    Ping Wang
    Cancer Cell International, 14
  • [30] Generation of Anti-c-Met Single Domain Antibody Fragment Based on Human Stable Frameworks
    Edwardraja, Selvakumar
    Sokalingam, Sriram
    Raghunathan, Govindan
    Hwang, Bum-Yeol
    Lee, Sun-Gu
    BIOTECHNOLOGY AND BIOPROCESS ENGINEERING, 2012, 17 (06) : 1120 - 1127
12345